Sentences with phrase «at biotechnology companies»

A few programs serve science graduates who want to go into toxicology; UW, for example, just launched a certificate program in biologics safety to teach basic toxicology to scientists working at biotechnology companies that develop protein and other medicines based on large molecules.
Madeline Butler, academic coordinator for undergraduate laboratories in the division of biological sciences at the University of California, San Diego (UCSD), says, «Our students with undergraduate degrees in biology seem to do well getting jobs in academic institutions and at biotechnology companies
Dr. Peter H. Diamandis, chairman of the X Prize Foundation, and Dr. Robert Hariri, founder and chief scientific officer of cell therapy operations at the biotechnology company Celgene, are both co-founders.
What to Expect in the 6th Week of Pregnancy After working as a chemist at a biotechnology company, Leah is now a freelance writer and enjoys exploring new places.
Philippe Durand and Marie - Hélène Perrard at the biotechnology company Kallistem in Lyon, France, say that their method coaxes seminiferous tubules — tissue that produces sperm in the testes — taken from humans, rats or monkeys into producing mature sperm cells.
In their current study, Croft and his team, in collaboration with researchers at the biotechnology company Biogen, focused on TWEAK and its receptor, Fn14, which had previously been shown to participate in several inflammatory conditions such as inflammatory bowel disease, arthritis and lupus - like kidney disease.
In contrast, let's look at the biotechnology company Biogen Inc. (BIIB) which trades at a very high price per share of $ 257.85 per share, which is roughly 100 times higher than we saw with Yamana Gold Inc. above.
He last worked as general counsel at biotechnology company Tengion.
Prior to attending law school, Ms. Nicholas began her career in human resources at a biotechnology company which included expertise in benefits, employee issues, and administration of requests for leave.
I also have over 5 years» experience as a Field Application Specialist with a biotech company which is a similar position as a Pre-sales and Medical Device Expert at a biotechnology company.

Not exact matches

To better measure the success of the companies on Inc.'s 2017 Founders 10 list, EY studied median benchmarks for the biotechnology, life sciences, pharmaceutical, and technology sectors at the time of their IPOs and one, two, and three years later.
Derek's primary responsibility at RA Capital is to conduct due diligence on biotechnology companies.
Ryan's primary responsibility at RA Capital is to is to conduct due diligence on biotechnology companies.
Neta's primary responsibility at RA Capital is to conduct due diligence on biotechnology companies.
Jake's primary responsibility at RA Capital is to conduct due diligence on biotechnology companies.
To gain exposure to health care or biotech companies, investors may want to take a look at the iShares Nasdaq Biotechnology ETF (IBB) or the iShares U.S. Healthcare ETF (IYH).
22nd Century Group, Inc. (XXII), a plant biotechnology company that is a provider of tobacco harm reduction and development of proprietary hemp / cannabis strains, broke out above multi-year resistance near $ 1.50 in 2013, rallying to a record high a few months later at $ 6.36.
George Budwell (iShares Nasdaq Biotechnology Index): Although the biotech industry is growing by leaps and bounds at the moment, the fact remains that individual companies — and even titans of the industry like Gilead Sciences — are fraught with clinical, regulatory, and commercial risk.
The «New York is losing» theme continued in Buffalo, where Astorino met reporters at ZeptoMetrix, a biotechnology company owned by Collins.
He holds more than 1000 patents, licensed or sublicensed to more than 300 companies, and he has helped found at least two dozen biotechnology companies.
If that doesn't work, find the standard format a company uses — for example, Robert Smith at ABC Biotechnology might be r.smith [at] abcbiotech.com — and there's a good chance that the other ABC email addresses use the same protocol.
Even though Rienhoff is the founder of two biotechnology companies and holds a medical degree from Johns Hopkins University, he has conducted his hunt not as an expert in human genomics but as a do - it - yourself biologist, teaching himself the tricks of the trade as he moves along and doing his research at home.
Whether the work is done at government institutions, universities or drug companies, the biotechnology boost to vaccine research is creating new opportunities to do vital work.
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single - molecule interactions between DNA and enzymatic proteins.
In addition, «what attracts people to biotech rather than pharma is that decision lines are much shorter; there is an easy access to everyone in the company,» comments Nicolas Hollanders, a recruitment consultant specialising in biotechnology at Egon Zehnder International in Brussels.
«If you put humans as the target, even though you are not going to make a human baby, it will be provocative, it will be misinterpreted, but people will engage,» says Andrew Hessel, a self - described futurist and biotechnology catalyst at Autodesk in San Francisco, California, a successful software company that specializes in 3D design programs for architecture and other fields that has been exploring synthetic biology applications in recent years.
This year like all others, scientists want to work at companies that keep innovation front and center, and the top 20 employers in 2015 include those biotechnology and pharmaceutical firms on the leading edge of these advances.
The biotechnology and pharmaceutical sectors have emerged from the global recession to find technological breakthroughs driving renewed enthusiasm and risk - taking at companies.
«I think there is a lot of uncertainty out there in the world right now,» says Will West, chief executive at CellCentric, a biotechnology company in Cambridge, United Kingdom.
As Science Careers noted 5 years ago, a group of young scientists at WUSTL took matters into their own hands, creating the volunteer - run BALSA (or Biotechnology and Life Sciences Advising) Group, which hires out five - person interdisciplinary teams — sometimes including law or business students along with scientists — to do approximately 6 - week - long consulting projects for companies, universities, and other organizations.
Student - and staff - led groups at universities and biotechnology companies are helping to support and promote diversity in these settings.
Syngenta's collaborative nature initially unnerved Michiel van Lookeren Campagne, Syngenta's head of biotechnology «My first meeting at the company, we sat in a round circle of chairs,» he says, «and I wondered «where did I land?»»
About 23 % of the money available in 2014 will go to projects aimed at boosting Europe's «industrial leadership» in areas such as space, information and communication technology, and biotechnology, with a special effort to boost the participation of small companies.
Once you've done that, find out what forces are at work in that cluster to promote the development of biotechnology start - up companies.
At Amgen, a biotechnology company with headquarters in Thousand Oaks, California, minorities are 24.7 percent of officials and managers and 36.2 percent of professionals.
At biotechnology and pharmaceutical companies, affinity groups have been integrated into the business fabric of many companies.
For instance, individuals at the North Carolina Biotechnology Center were instrumental in identifying panelists and establishing contacts with company representatives.
Scientists seeking to exploit their discoveries by setting up new biotechnology companies face a difficult choice: They must either spend time learning how to run a business on a lengthy, full - time course such as an MBA, or they take the risk and plunge in at the deep end, taking advice from consultants.
Robert Phillips was a CASE student at the University of Southampton and the Swedish biotechnology company Actinova.
Companies in the consortium locate postdocs at universities and offer them funding to work on industry projects in such areas as nanobiotechnology, marine biotechnology, and vaccine development.
«An entire generation of biotech projects was being shelved,» says Alan Eisenberg, executive vice president for Emerging Companies and Business Development at the Biotechnology Industry Organization in Washington, D.C. BIO pushed for the program along with patient - advocacy groups.
The antibody - based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology company, is a simple, cost - effective way to determine if a person's infection is from the Zika virus or another virus of the same family, such as dengue and West Nile viruses.
The biotechnology and pharmaceutical industry usually pops up first in many people's minds, with companies in that sector continuing to hire scientists at both the B.S. and M.S. levels.
I found that out by participating in a test conducted at the Linguagen Corporation, a biotechnology company in Cranbury, New Jersey.
My laboratories at Harvard and my biotechnology companies were staffed by both brilliant young Americans and the best young minds from abroad.
Full of energy and enthusiasm, he realised he was overqualified — there were no biotechnology companies in Portugal at the time, and most of the pharmaceutical companies were simply manufacturing generics and did not have R&D departments.
Winter is former deputy director of the Laboratory of Molecular Biology at the Medical Research Council in Cambridge, U.K., and founder of several biotechnology companies; he was appointed Master of Trinity College at the University of Cambridge in December 2011.
Abnormal levels of the proteins may be useful biomarkers that could help us study early treatments to limit or reverse the damage to brain cells and even prevent the development of the full - blown disease,» said study author Edward Goetzl, MD, a Professor of Medicine with the University of California, San Francisco, a researcher at the National Institute on Aging, and a scientist of NanoSomiX, Inc., a California - based biotechnology company that provided a grant for method development for the study.
Robert Lanza, vice president of medical and scientific development at the privately - held biotechnology company Advanced Cell Technology (ACT), says that without scientific data, he is extremely skeptical of the group's claim.
The commission fears that the government is giving too much credence to complaints from biotechnology companies that rigorous testing would put them at a disadvantage compared with rivals in the US and Japan.
a b c d e f g h i j k l m n o p q r s t u v w x y z